Mayo Clinic Study Finds Using Convalescent Plasma To Treat COVID-19 Appears Safe
The study assessed patients at risk for severe or life-threatening effects, seven days after their plasma transfusion. They found mortality rates declined to 8.6%, compared to to 12% from a previous safety study.